Clinically Relevant Drug Product Specifications: Methods of Establishment
Testing a Claim about Standard Deviation
Uncertainty in Measurement: Significant Figures
Design Consideration
Statistical Analysis: Overview
Bioequivalence Data: Statistical Interpretation
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Apr 21, 2026

Simulation of a Scaled Assembly Process with Collaboration of a Robotic Arm and Monitoring through a Vision System for Quality Control
Published on: August 29, 2025
Xiaoyu Dong1, Yi Tsong, Meiyu Shen
1a Office of Biostatistics , /Office of Translational Sciences, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring , Maryland , USA.
This study evaluates statistical methods for setting drug product specifications, comparing approaches like reference intervals and tolerance intervals to ensure product quality. Recommendations are provided for selecting appropriate methods to establish robust acceptance criteria.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: